Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Oil edges up as OPEC cuts, U.S. inventories brighten outlook
By Laila Kearney April 5 (Reuters) – Oil prices rose in early Asian trade on Wednesday on anticipated U.S. crude inventory declines and OPEC+’s latest
China's New Weapon: Dragging Its Feet on Deals Involving American Companies
Beijing has slowed down antitrust reviews of proposed deals by American firms, people close to the process say. Source link
POLL-Emerging market currencies to gain as U.S. Fed nears endgame
By Vivek Mishra BENGALURU, April 5 (Reuters) – Most emerging market currencies are forecast to drift higher over the coming year as investors fret less
Stellantis, BMW in Talks With Panasonic Over New EV Battery Plants
The cylindrical batteries used by Tesla get a closer look from other car makers. Source link
Cantor Fitzgerald Maintains Biohaven Pharmaceutical Holding (BHVN) Overweight Recommendation
On April 4, 2023, Cantor Fitzgerald maintained coverage of Biohaven Pharmaceutical Holding with a Overweight recommendation. Analyst Price Forecast Suggests 77.58% Upside As of March
Who Owns SpongeBob? AI Shakes Hollywood's Creative Foundation
Artificial-intelligence tools raise questions about intellectual property rights that are under scrutiny by courts and entertainment executives Source link
Evercore ISI Group Maintains Baxter International (BAX) Outperform Recommendation
On April 4, 2023, Evercore ISI Group maintained coverage of Baxter International with a Outperform recommendation. Analyst Price Forecast Suggests 23.68% Upside As of March
Apple’s Weather App Is Working Again After More Than 14-Hour Outage
Tech Service may have been slow or unavailable, tech company says, without offering reason for outage Source link
Jamie Dimon Dishes on Banking Crisis in Annual Shareholder Letter
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It’s completely free and we guarantee you’ll learn something new
Hype Around Weight-Loss Drugs Shows No Signs of Abating. Neither Do the Ads.
Ads for the likes of Ozempic and Wegovy are spreading through social media feeds, subway stations and TV. Source link